CliffBio
small molecule

METOZOLV ODT

METOCLOPRAMIDE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanySalix Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETOZOLV ODT
Active ingredientMETOCLOPRAMIDE HYDROCHLORIDE
StrengthEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, ORALLY DISINTEGRATING
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2009
Marketing statusDISCN

More from Salix Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.